Previous Close | 597.42 |
Open | 601.07 |
Bid | 239.28 x 900 |
Ask | 599.71 x 800 |
Day's Range | 597.26 - 603.90 |
52 Week Range | 492.84 - 654.62 |
Volume | |
Avg. Volume | 79,472 |
Market Cap | 9.089B |
Beta (5Y Monthly) | 0.42 |
PE Ratio (TTM) | 33.51 |
EPS (TTM) | 17.92 |
Earnings Date | Apr 24, 2024 |
Forward Dividend & Yield | 1.60 (0.27%) |
Ex-Dividend Date | Feb 23, 2024 |
1y Target Est | 690.00 |
Investors are optimistic about Chemed (CHE), backed by the strong performance of the VITAS Healthcare and Roto-Rooter segments.
CINCINNATI, April 17, 2024--VITAS Healthcare Corporation, a wholly-owned subsidiary of Chemed Corporation ("Chemed") (NYSE: CHE) announced the completion of the previously announced purchase of all hospice operations and an assisted living facility from Covenant Health and Community Services, Inc. d/b/a/ Covenant Care ("Covenant") for an aggregate purchase price of $85 million. The transaction is structured as an asset purchase.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.